Pancreatic Cancer Research

ResearcherAffiliated Hospital of North Sichuan Medical CollegeActive in the last 2 years

Guangnian Zhang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113108139. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Glycosylated hypoxic tumour-derived extracellular vesicles as a targeted siRNA delivery system to remodel the immunosuppressive microenvironment in pancreatic … Co-author DOI 10.1080/1061186x.2026.2730297↗
  2. Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study. Co-author DOI 10.3389/fonc.2025.1521616↗
  3. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer. Co-author DOI 10.3389/fimmu.2024.1341209↗
  4. Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer via the Wnt/β-catenin pathway Co-author DOI 10.21203/rs.3.rs-1976828/v1↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianshui Li · 3 shared papers, 2022–2025 · strength 0.55
  2. Dawei Deng · 3 shared papers, 2022–2025 · strength 0.55
  3. Chuan Lan · 3 shared papers, 2022–2025 · strength 0.55
  4. Dongmei Ren · 2 shared papers, 2024–2026 · strength 0.55
  5. Jun Qing Yu · 2 shared papers, 2024–2025 · strength 0.42
  6. Yong Li · 2 shared papers, 2024–2025 · strength 0.42
  7. Zhenglong Liu · 1 shared paper, 2026 · strength 0.36
  8. Yi Chen · 1 shared paper, 2025 · strength 0.22
  9. Yifu Hou · 1 shared paper, 2024 · strength 0.20
  10. Xiaobin Huang · 1 shared paper, 2022 · strength 0.13
  11. Jun Yu · 1 shared paper, 2022 · strength 0.13
  12. Xingyu Liu · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.